Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
solifenacin succinate, Quantity: 10 mg
Arrotex Pharmaceuticals Pty Ltd
Solifenacin succinate
Tablet, film coated
Excipient Ingredients: lactose; titanium dioxide; croscarmellose sodium; magnesium stearate; macrogol 8000; polyvinyl alcohol; purified talc; hyprolose; iron oxide red
Oral
30
(S4) Prescription Only Medicine
Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.
Visual Identification: Light pink coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 10' on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2016-01-12